Characteristics | Organizations producing CPGs (n = 31) | Organizations producing HTAs (n = 19) | Organizations producing CPGs and HTAs (n = 45) | Organizations supporting government policymaking (n = 57) |
---|---|---|---|---|
Average number of members in a CPG or HTA development panel | ||||
1–5 full time equivalents (FTE) | 17 (55%) | 11 (58%) | 23 (51%) | - |
6–10 FTE | 9 (29%) | 5 (26%) | 11 (24%) | - |
11–15 FTE | 2 (6%) | 0 (0%) | 5 (11%) | - |
16–20 FTE | 1 (3%) | 1 (5%) | 1 (2%) | - |
> 20 FTE | 2 (6%) | 1 (5%) | 3(7%) | - |
Not reported | 1 (3%) | 1 (5%) | 1 (2%) | - |
Average number of staff involved in service delivery | ||||
< 0.5 full time equivalents (FTE) | - | - | - | 8 (14%) |
0.5 – 1.9 FTE | - | - | - | 6 (11%) |
> 2 FTE | - | - | - | 37 (65%) |
Types of experts/stakeholders who were always involved* | ||||
Information/library science | 19 (61%) | 16 (84%) | 27 (60%) | 29 (51%) |
Clinical epidemiology | 21 (68%) | 14 (74%) | 32 (71%) | 24 (42%) |
Biostatistics | 3 (10%) | 6 (32%) | 17 (38%) | 23 (40%) |
Health economics | 5 (16%) | 10 (53%) | 17 (38%) | 24 (42%) |
Other types of social scientists | 4 (13%) | 4 (21%) | 12 (27%) | 23 (40%) |
Knowledge transfer/communications | 10 (32%) | 8 (42%) | 21 (47%) | 24 (42%) |
Consumer | 9 (29%) | 3 (16%) | 17 (38%) | 15 (26%) |
Other | 7 (23%) | 9 (47%) | 13 (29%) | 15 (26%) |
Types of experts/stakeholders who were involved only if necessary* | ||||
Information/library science | 10 (32%) | 2 (11%) | 13 (29%) | 22 (39%) |
Clinical epidemiology | 8 (26%) | 4 (21%) | 11 (24%) | 22 (39%) |
Biostatistics | 16 (52%) | 12 (63%) | 19 (42%) | 26 (46%) |
Health economics | 15 (48%) | 9 (47%) | 23 (51%) | 26 (46%) |
Other types of social scientists | 14 (45%) | 15 (79%) | 26 (58%) | 24 (42%) |
Knowledge transfer/communications | 8 (26%) | 8 (42%) | 9 (20%) | 23 (40%) |
Consumer | 12 (39%) | 11 (58%) | 11 (24%) | 24 (42%) |
Other | 2 (6%) | 4 (21%) | 3 (7%) | 5 (9%) |
Involvement of target users in product development or service delivery | ||||
By participation in development/delivery group | 25 (81%) | 11 (58%) | 33 (73%) | - |
By survey of views/preferences | 9 (29%) | 2 (11%) | 18 (40%) | - |
By review of draft product or service model | 22 (71%) | 9 (47%) | 32 (71%) | - |
No | 0 (0%) | 3 (16%) | 3 (7%) | |
Not reported | 0 (0%) | 2 (11%) | 1 (2%) | - |
Involvement of consumers (patients or general public) in product development or service delivery | ||||
By participation in development group | 12 (39%) | 3 (16%) | 16 (36%) | 25 (44%) |
By survey of views/preferences | 9 (29%) | 2 (11%) | 14 (31%) | 31 (54%) |
By review of draft guideline (or HTA) | 14 (45%) | 5 (26%) | 23 (51%) | 17 (30%) |
No | 10 (32%) | 9 (47%) | 13 (29%) | 15 (26%) |
Not reported | 1 (3%) | 2 (11%) | 1 (2%) | 1 (2%) |
Criteria used in expert and/or target user selection* | ||||
Geographic balance | 21 (68%) | 7 (37%) | 18 (40%) | - |
Gender balance | 8 (26%) | 2 (11%) | 8 (18%) | - |
Other | 18 (58%) | 11 (58%) | 25 (56%) | - |